October 1, 2022
Ophthalmic Drugs Market

According to the latest report by IMARC Group, “Global Ophthalmic Drugs Market Report: Size, Share, Growth, Industry Trends, Opportunity and Forecast 2022-2027“, the global ophthalmic drugs market reached a value of US$ 40.47 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 56.25 Billion by 2027, exhibiting a CAGR of 5.40% during 2022-2027.

Ophthalmic drugs are specifically designed and regulated for the treatment of numerous eye diseases such as diabetic macular edema, age-related macular degeneration, color blindness and cytomegalovirus. They are produced from antibiotics, polymyxin, neomycin and dendrimers that assist in reducing the growth of bacterial infection in the eye. These medicines are available in the forms of aqueous gels, nanosuspensions, contact lenses, dendrimers, and emulsions ointments. Presently, they are available in liquid, solid and semi-solid formulation types.

Ophthalmic Drugs Market Trends and Drivers:

One of the key factors driving the market is the rising instances of several eye disorders such as glaucoma, color blindness and visual impairment. Additionally, the rising awareness about the anti-inflammatory properties of the drug helps treat various diseases, such as cystoid macular edema, scleritis, and uveitis disorder, which is escalating its demand globally.

Request Free Sample Report: https://www.imarcgroup.com/ophthalmic-drugs-market/requestsample

Besides, the launch of gene-drug therapies for treating and diagnosing hereditary ophthalmic, retinoblastoma disorders and nano vascular retinal are propelling the market growth. Moreover, the accessibility of these drugs in drops, gels, capsules, tablets, eye solutions and ointment forms across offline and online platforms represents another major growth-inducing factor.

Furthermore, the significant funding and favorable initiatives undertaken by governments of several nations to encourage the production of effective ophthalmic drugs with unfamiliar combinations are contributing to the market growth. In confluence with this, the increasing research and development (R&D) activities to launch cost-effective ocular drug delivery systems (ODDS) and the extensive expansion in the pharmaceutical industry are other factors creating a positive market outlook.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global Ophthalmic Drugs Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

AbbVie Inc., Aerie Pharmaceuticals Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche AG, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd. and Sun Pharmaceutical Industries Ltd.

The report has segmented the market on the basis of region, type, drug class, indication, dosage form and distribution channel.

Breakup by Type:

  • Prescription Drugs
  • Over-the-counter Drugs

Breakup by Drug Class:

  • Anti-glaucoma
  • Anti-infection
  • Anti-inflammation
  • Anti-allergy
  • Others

Breakup by Indication:

  • Dry Eye
  • Glaucoma
  • Infection/Inflammation/Allergy
  • Retinal Disorders
  • Others

Breakup by Dosage Form:

  • Liquid Ophthalmic Drug Forms
  • Solid Ophthalmic Drug Forms
  • Semisolid Ophthalmic Drug Forms
  • Multicompartment Drug Delivery Systems
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published.